Seeing Is Believing
Currently out of the existing stock ratings of David Styblo, 53 are a BUY (79.1%), 14 are a HOLD (20.9%).
Analyst David Styblo, carries an average stock price target met ratio of 89.21% that have a potential upside of 37.5% achieved within 491 days. Previously, David Styblo worked at JEFFERIES.
David Styblo’s has documented 115 price targets and ratings displayed on 7 stocks. The coverage was on Financial Services, Healthcare, Industrials sectors.
Most recent stock forecast was given on MGLN, Magellan Health at 15-Jan-2021.
Analyst best performing recommendations are on EHTH (EHEALTH).
The best stock recommendation documented was for EHTH (EHEALTH) at 2/27/2017. The price target of $11.5 was fulfilled within 1 day with a profit of $0.23 (1.96%) receiving and performance score of 19.61.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-Jan-2025
$443
$117.93 (36.28%)
$448
22 days ago
(02-Feb-2026)
24/31 (77.42%)
$93.39 (26.71%)
151
Buy Since 09-Oct-2025
$412
$86.93 (26.74%)
$393
22 days ago
(02-Feb-2026)
1/4 (25%)
$62.39 (17.85%)
365
Buy Since 08-Jan-2024
$406
$80.93 (24.90%)
$433
1 months 17 days ago
(07-Jan-2026)
10/14 (71.43%)
$56.83 (16.28%)
155
Buy Since 30-Jul-2024
$416
$90.93 (27.97%)
$410
1 months 18 days ago
(06-Jan-2026)
5/15 (33.33%)
$67.08 (19.23%)
97
Hold Since 08-Jan-2019
$389
$63.93 (19.67%)
$329
2 months 8 days ago
(16-Dec-2025)
11/12 (91.67%)
$37.95 (10.81%)
171
What Year was the first public recommendation made by David Styblo?